CRIS Current Research Information System

MARTIGNANI, CRISTIAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.251
AS - Asia 10.511
EU - Europa 9.175
AF - Africa 603
SA - Sud America 548
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 5
Totale 32.114
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.142
VN - Vietnam 3.168
SG - Singapore 2.771
CN - Cina 2.423
GB - Regno Unito 2.205
IT - Italia 2.150
DE - Germania 1.171
HK - Hong Kong 756
UA - Ucraina 715
SE - Svezia 673
FR - Francia 612
RU - Federazione Russa 504
IN - India 479
BR - Brasile 389
IE - Irlanda 276
NL - Olanda 209
JP - Giappone 200
CI - Costa d'Avorio 191
EE - Estonia 178
KR - Corea 173
FI - Finlandia 161
ZA - Sudafrica 161
BD - Bangladesh 120
TG - Togo 85
AR - Argentina 75
SC - Seychelles 73
PH - Filippine 65
CH - Svizzera 63
BG - Bulgaria 57
JO - Giordania 54
CA - Canada 50
IQ - Iraq 43
TH - Thailandia 43
NG - Nigeria 40
MX - Messico 36
BE - Belgio 35
IR - Iran 31
AT - Austria 29
ID - Indonesia 29
PL - Polonia 27
TW - Taiwan 24
PK - Pakistan 23
TR - Turchia 23
EC - Ecuador 22
SA - Arabia Saudita 22
GR - Grecia 21
AU - Australia 19
ES - Italia 17
CL - Cile 15
RO - Romania 15
EG - Egitto 14
UZ - Uzbekistan 14
CO - Colombia 13
PY - Paraguay 11
MA - Marocco 10
UY - Uruguay 8
CZ - Repubblica Ceca 7
LT - Lituania 7
MY - Malesia 7
PE - Perù 7
VE - Venezuela 7
DZ - Algeria 6
LB - Libano 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
KZ - Kazakistan 5
OM - Oman 5
PT - Portogallo 5
RS - Serbia 5
ET - Etiopia 4
HR - Croazia 4
HU - Ungheria 4
JM - Giamaica 4
NO - Norvegia 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
AL - Albania 3
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EU - Europa 3
IL - Israele 3
LU - Lussemburgo 3
MN - Mongolia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
DK - Danimarca 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
Totale 32.093
Salva come PNG Salva come JPEG
Città #
Southend 1.919
Singapore 1.911
Ashburn 1.132
Fairfield 954
San Jose 872
Hong Kong 713
Chandler 632
Ho Chi Minh City 585
Jacksonville 524
Santa Clara 509
Wilmington 494
Hanoi 466
Seattle 451
Dong Ket 449
Woodbridge 444
Princeton 442
Houston 425
Hefei 344
Beijing 315
Cambridge 310
Ann Arbor 285
Dublin 276
Boardman 273
Lauterbourg 210
Los Angeles 206
Westminster 201
Padova 200
Nanjing 197
Council Bluffs 194
Abidjan 191
Tokyo 182
Milan 176
Bologna 169
Helsinki 139
New York 138
Seoul 130
Rome 123
Berlin 122
Saint Petersburg 112
Buffalo 106
Shenyang 103
Medford 101
Jinan 93
Bremen 92
Changsha 90
Lomé 85
Mülheim 82
Dallas 80
Da Nang 75
Turin 74
San Diego 69
Mahé 67
Nanchang 64
Haiphong 63
Frankfurt am Main 61
São Paulo 58
Guangzhou 57
Sofia 57
Munich 54
Hebei 53
Amman 51
Redondo Beach 48
The Dalles 44
Bern 43
Des Moines 43
Olalla 43
Jiaxing 42
Tianjin 42
Abeokuta 38
Naples 37
Verona 37
Zhengzhou 37
Shanghai 36
Chicago 35
Bari 34
Bengaluru 33
Brussels 33
Hải Dương 33
Hangzhou 32
Ningbo 31
Phoenix 30
Biên Hòa 28
Yubileyny 27
Can Tho 26
Falkenstein 25
London 25
Norwalk 24
Florence 23
Haikou 22
Mountain View 22
Ninh Bình 22
Dearborn 21
San Francisco 21
Taizhou 21
Baghdad 19
Brooklyn 19
Chengdu 19
Düsseldorf 19
Johannesburg 19
Lanzhou 19
Totale 20.222
Salva come PNG Salva come JPEG
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.117
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 309
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 290
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 264
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 251
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 250
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 230
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 229
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 223
AF burden is important - Fact or fiction? 218
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 217
Aritimie cardiache, morte cardiaca improvvisa, sincope 216
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 209
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 207
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 207
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 205
Electrocardiographic remodeling during cardiac resynchronization therapy 202
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 200
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 199
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 198
Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study 197
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 197
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 195
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 194
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 193
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 193
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 192
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 186
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 186
Atrial fibrillation ablation: beyond electro-mechanical matters 184
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 183
Implantation of cardioverter-defibrillator: Effects on shoulder function. 180
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 180
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 178
Is Less Always More? A Prospective Two-Centre Study Addressing Clinical Outcomes in Leadless versus Transvenous Single-Chamber Pacemaker Recipients 177
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 176
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 176
Preoperative checklist to reduce the risk of cardiac implantable electronic device infections 176
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 175
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 175
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 174
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 173
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 173
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 173
Rate control in AFFIRM: considerations about the clinical implications. 171
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. 171
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 171
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 170
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 170
Is ventricular sensing always right, when it is left? 169
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 169
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 167
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 166
Predictors of long-term survival free from relapses after extraction of infected CIED. 166
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 166
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 165
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 164
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 164
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 161
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 159
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 158
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 158
Poor Glycaemic Control and Arrhythmias. 158
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 158
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 158
Atrial fibrillation and heart failure: does one epidemic feed he other? 157
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 155
Long-Term Atrioventricular Block Following Valve Surgery: Electrocardiographic and Surgical Predictors 153
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 153
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 153
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 153
The QRS interval in patients treated with resynchronization therapy: which value 152
Phrenic stimulation: a challenge for cardiac resynchronization therapy 152
Non-valvular atrial fibrillation: Potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants 152
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry 151
Effetti emodinamici del pacing biventricolare a distanza di un anno dall'impianto 151
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 151
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. 150
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 149
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia 148
Biventricular pacing in heart failure: what relationship between electrocardiographic and structural remodeling? 147
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 147
Follow-up a lungo termine di pazienti con sincope valutati con tilt test 146
Atrial fibrillation in patients with cardiac resynchronization therapy: Clinical management and outcome 146
The Challenges of Diagnosis and Treatment of Arrhythmogenic Cardiomyopathy: Are We there yet? 145
Ventricular dyssynchrony at rest and during exercise assessed by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 145
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 145
Is cardiac resynchronization therapy cost-effective? 145
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 145
Cardiac resynchronization by pacing: an electrical treatment of heart failure 145
Risultati a lungo termine della cardioversione elettrica di fibrillazione o flutter atriale. 144
Single versus dual-chamber ICDs : evaluation of rhythm discrimination QRS morphology. 144
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 143
Atrial fibrillation in patients with a dual defibrillator: characteristics of spontaneous and induced episodes and effect of ventricular tachyarrhythmia induction. 143
Atrioventricular Block Treatment: Pacing Site, AV Synchrony, or Both? 142
Cardioversione elettrica di fibrillazione e flutter atriale: risultati a distanza. 142
A plateau waveform shape allows a much higher patient shock energy tolerance 142
Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death 141
La cardioversione elettrica nella pratica clinica:quali predittori di efficacia della procedura e di recidiva di fibrillazione/flutter atriale a lungo termine? 141
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 141
Totale 18.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.774
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.303 0 0 0 0 0 0 0 0 0 0 0 1.303
2021/20223.403 334 173 219 292 326 228 48 271 104 154 607 647
2022/20233.769 365 452 189 501 217 221 115 196 666 218 319 310
2023/20241.162 93 178 88 79 119 228 83 75 62 58 40 59
2024/20254.275 189 797 318 312 801 196 189 111 56 268 177 861
2025/20269.853 887 854 949 678 1.005 579 1.115 681 1.687 744 331 343
Totale 32.609